Correction: Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway

D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs quantifying the number of colonies formed, indicating a signifcant increase in colony formation upon IL-11 treatment. Bar graphs showing the percent...

Full description

Saved in:
Bibliographic Details
Published inJournal of experimental & clinical cancer research Vol. 43; no. 1; pp. 333 - 4
Main Authors Cheng, Bisheng, Li, Lingfeng, Luo, Tianlong, Wang, Qiong, Luo, Yong, Bai, Shoumin, Li, Kaiwen, Lai, Yiming, Huang, Hai
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 28.12.2024
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs quantifying the number of colonies formed, indicating a signifcant increase in colony formation upon IL-11 treatment. Bar graphs showing the percentage of dead cells in prostate cancer cell lines PC3 (I) and DU145 (J), comparing the control and IL-11-treated groups. *P<0.05, **P<0.01, ***P<0.001 Full size image Correct Fig. 4 Fig. 4 figure 2 IL-11 contributes to increased viability and chemoresistance in prostate cancer cells. D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs quantifying the number of colonies formed, indicating a signifcant increase in colony formation upon IL-11 treatment. Bar graphs showing the percentage of dead cells in prostate cancer cell lines PC3 (I) and DU145 (J), comparing the control and IL-11-treated groups. *P<0.05, **P<0.01, ***P<0.001 Full size image The correction does not compromise the validity of the conclusions and the overall content of the article.
AbstractList D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs quantifying the number of colonies formed, indicating a signifcant increase in colony formation upon IL-11 treatment. Bar graphs showing the percentage of dead cells in prostate cancer cell lines PC3 (I) and DU145 (J), comparing the control and IL-11-treated groups. *P<0.05, **P<0.01, ***P<0.001 Full size image Correct Fig. 4 Fig. 4 figure 2 IL-11 contributes to increased viability and chemoresistance in prostate cancer cells. D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs quantifying the number of colonies formed, indicating a signifcant increase in colony formation upon IL-11 treatment. Bar graphs showing the percentage of dead cells in prostate cancer cell lines PC3 (I) and DU145 (J), comparing the control and IL-11-treated groups. *P<0.05, **P<0.01, ***P<0.001 Full size image The correction does not compromise the validity of the conclusions and the overall content of the article.
ArticleNumber 333
Audience Academic
Author Li, Lingfeng
Li, Kaiwen
Cheng, Bisheng
Lai, Yiming
Huang, Hai
Bai, Shoumin
Wang, Qiong
Luo, Yong
Luo, Tianlong
Author_xml – sequence: 1
  givenname: Bisheng
  surname: Cheng
  fullname: Cheng, Bisheng
– sequence: 2
  givenname: Lingfeng
  surname: Li
  fullname: Li, Lingfeng
– sequence: 3
  givenname: Tianlong
  surname: Luo
  fullname: Luo, Tianlong
– sequence: 4
  givenname: Qiong
  surname: Wang
  fullname: Wang, Qiong
– sequence: 5
  givenname: Yong
  surname: Luo
  fullname: Luo, Yong
– sequence: 6
  givenname: Shoumin
  surname: Bai
  fullname: Bai, Shoumin
– sequence: 7
  givenname: Kaiwen
  surname: Li
  fullname: Li, Kaiwen
– sequence: 8
  givenname: Yiming
  surname: Lai
  fullname: Lai, Yiming
– sequence: 9
  givenname: Hai
  orcidid: 0000-0002-2013-073X
  surname: Huang
  fullname: Huang, Hai
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39731134$$D View this record in MEDLINE/PubMed
BookMark eNp9k02P0zAQhiO0iP2AP8ABWUJCXLIbx47jcEFVxUdhJQ5bztbEmbRepXaxncL-KP4jbruL2hVCPsSaed7XznjmPDuxzmKWvaTFJaVSXAXKCi7youR5wcqqzuWT7IzWlcibRoiTg_1pdh7CbVEI2tDmWXbKmppRyvhZ9nvqvEcdjbPvyI2xiwFzjcNAOtTObtwwblMEhoXzJi5XgYCF4S6YQEa7QTOkwBid9sYimV1Tmq-wMxCxIx4TFcFqJNGRzmmM8AsHYixZe5cyEYnepj3ZGCCQLrGB3WmuJ3GJ5MvkK726mU_mnKwhLn_C3fPsaQ9DwBf334vs-8cP8-nn_Prbp9l0cp1rzguZM459WYsOa9og1VjIvmUCC1r3UmJVt8BRyEazllPBOdRt2yYJ1FXTdknCLrLZ3rdzcKvW3qzA3ykHRu0Czi8U-Gj0gIojArZdWVW04wKpLFkJQmqN5TYAyev93ms9tqk2Gm30MByZHmesWaqF2yhKhaRCFMnh7b2Ddz9GDFGtTNg-Elh0Y1CM8qauZCVYQl8_Qm_d6NOLJaosqJRNUx1QC0h_YGzv0sF6a6omsqTJitVloi7_QaXV4cqk5sDepPiR4M2BYIkwxGW476BwDL46LMnfWjy0ZQLkHtCpUYLHXmkTd72RrmAGRQu1nQC1nwCVJkDtJkDJJC0fSR_c_yP6A_qqCZ8
CitedBy_id crossref_primary_10_32948_auo_2024_12_25
Cites_doi 10.1186/s13046-024-02962-8
ContentType Journal Article
Copyright COPYRIGHT 2024 BioMed Central Ltd.
2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2024 2024
Copyright_xml – notice: COPYRIGHT 2024 BioMed Central Ltd.
– notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2024 2024
DBID AAYXX
CITATION
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13046-024-03257-8
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-9966
EndPage 4
ExternalDocumentID oai_doaj_org_article_4eeaebd2551d46e18232a68cce21d46a
PMC11681660
A821585372
39731134
10_1186_s13046_024_03257_8
Genre Published Erratum
Correction/Retraction
GroupedDBID ---
0R~
29K
2WC
4.4
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ADBBV
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
D-I
DIK
DU5
E3Z
EBD
EBLON
EBS
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
~8M
-5E
-5G
-A0
-BR
3V.
ACRMQ
ADINQ
C24
NPM
PMFND
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c4408-34ef276de719e1ce08fb36e017f88e57ba4e689c3b41644a7bbb4efa759bd19e3
IEDL.DBID M48
ISSN 1756-9966
0392-9078
IngestDate Wed Aug 27 01:21:29 EDT 2025
Thu Aug 21 18:29:44 EDT 2025
Fri Jul 11 15:32:08 EDT 2025
Fri Jul 25 09:24:23 EDT 2025
Tue Jun 17 21:59:50 EDT 2025
Tue Jun 10 21:04:04 EDT 2025
Thu May 22 21:24:04 EDT 2025
Wed Feb 19 02:01:33 EST 2025
Tue Jul 01 02:26:54 EDT 2025
Thu Apr 24 23:10:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4408-34ef276de719e1ce08fb36e017f88e57ba4e689c3b41644a7bbb4efa759bd19e3
Notes correction
ObjectType-Correction/Retraction-1
SourceType-Scholarly Journals-1
content type line 14
content type line 23
ORCID 0000-0002-2013-073X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s13046-024-03257-8
PMID 39731134
PQID 3201889953
PQPubID 105475
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_4eeaebd2551d46e18232a68cce21d46a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11681660
proquest_miscellaneous_3149758563
proquest_journals_3201889953
gale_infotracmisc_A821585372
gale_infotracacademiconefile_A821585372
gale_healthsolutions_A821585372
pubmed_primary_39731134
crossref_citationtrail_10_1186_s13046_024_03257_8
crossref_primary_10_1186_s13046_024_03257_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20241228
PublicationDateYYYYMMDD 2024-12-28
PublicationDate_xml – month: 12
  year: 2024
  text: 20241228
  day: 28
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of experimental & clinical cancer research
PublicationTitleAlternate J Exp Clin Cancer Res
PublicationYear 2024
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References B Cheng (3257_CR1) 2024; 43
38429845 - J Exp Clin Cancer Res. 2024 Mar 1;43(1):67. doi: 10.1186/s13046-024-02962-8
References_xml – volume: 43
  start-page: 67
  year: 2024
  ident: 3257_CR1
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-024-02962-8
– reference: 38429845 - J Exp Clin Cancer Res. 2024 Mar 1;43(1):67. doi: 10.1186/s13046-024-02962-8
SSID ssj0061919
Score 2.3909197
Snippet D Images of colony formation in prostate cancer cell lines PC3 and DU145, comparing the control and overexpression treated groups, alongside bar graphs...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 333
SubjectTerms Algorithms
Analysis
Antimitotic agents
Antineoplastic agents
Cancer
Care and treatment
Prostate cancer
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fb9QwDI_QHhAviP8UBgQJiQdU3aXJpSlvx8Q0BuNlN2lvUZK67KSune56B3woviN226uuQoIXXhNHamzH_rmJbcbepMqJLIU8RoFjgJLSmVMqiadQCGOUCZmg3OGzr_rkQp1ezi73Wn3Rm7CuPHDHuIkCcOBzRL4iVxoQDsvEaRMCJDTQQiP0ebtgqrPBGBWIbJciY_RkLegCMEZ_FE8lKmlsRm6ordb_p03ec0rjB5N7Huj4HrvbQ0c-7z75PrsF1QN2-6y_HH_Ifh1Rp402T-E9P0eXVEJM_-V5TkHvttcx7spv9WrZXF2vuesrkvBNtYVliQObpg6UD8g_fUGmtmklCEk5xuSEM1FBeFPzHH1e435AyZcVv6G0ESTigaZXfLt0nJIlul-9vC44Qkx-Ov8sJueL-UJx6oH83f18xC6OPy6OTuK-G0McqCt1LBUUSapzSEUGIsDUFF5qwBNdGAOz1DsF2mRBesR4SrnUe49LXDrLfI5L5GN2UNUVPGW8UGhhcVXhglAul8YXudEZ-MwlsxBkxMROODb0pcqpY0Zp25DFaNsJ1KJAbStQayL2blhz0xXq-Cv1B5L5QElFttsBVD3bq579l-pF7BVpjO0yVgdTYecGcRTCoDSJ2NuWgowFbiC4PucB2UBlt0aUhyNKPORhPL3TStsbmbWVCN4MxsszZNjrYZpW0sO5CuoN0mAETCGhRponnRIPm5bUtkxIFTEzUu8RV8Yz1fKqLUEuhKYL5-mz_8HH5-xOQkdTUKGAQ3bQrDbwAqFe41-2p_o3Gp1SiA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgSIgXxDeBAUZC4gFFq2PXcXhBZWIag_GyTuqb5TiXrVJJSpsW-KP4H7lL3LAIaa_2WUp8nz_bd8fYm1Q5kaVQxMhwBCgp6ZxSSTyCUhijjM8E5Q6fftPH5-pkNp6FA7d1eFa5s4mtoS5qT2fkBxI9lUFwMJYflj9i6hpFt6uhhcZNdotKl5FUp7MecCE2aBt7oIfUMcX1u6QZow_Wgq4EY_RQ8Uii2MZm4Jja-v3_W-krbmr4hPKKTzq6x-6GYJJPOu7fZzegesBun4br8ofszyH13mgzF97zM3RSC4jppJ4XBIO3Qeq4W1zgnzaX39fchRolfFNtYb7AgU1Te8oQ5J-_4ja3iSYYpHJE6RR5osjwpua4fdC4X7Dg84ovKZEEibin6RXfzh2n9Inu8JfXJcegk59MvoiDs-lkqjh1Rf7pfj9i50efpofHcejPEHvqUx1LBWWS6gJSkYHwMDJlLjWgjpfGwDjNnQJtMi9zjPqUcmme57jEpeMsL3CJfMz2qrqCp4yXCm0uriqdF8oV0uRlYXQGeeaSsfcyYmLHHOtD8XLqobGwLYgx2nYMtchQ2zLUmoi969csu9Id11J_JJ73lFR2ux2oVxc2aLFVAA7yAmGYKJQGxGYycdp4DwkNuIi9IomxXQ5rbzzsxGBkhYFRmkTsbUtB5gN_wLuQBYHbQIW4BpT7A0pUez-c3kmlDWZnbf8pScRe99O0kp7SVVBvkAYxMYFEjTRPOiHuf1pSIzMhVcTMQLwHuzKcqeaXbVFyITRdQY-eXf9dz9mdhJROUFGAfbbXrDbwAsO6Jn_Z6u5fbTZLRQ
  priority: 102
  providerName: ProQuest
Title Correction: Single-cell deconvolution algorithms analysis unveils autocrine IL11-mediated resistance to docetaxel in prostate cancer via activation of the JAK1/STAT4 pathway
URI https://www.ncbi.nlm.nih.gov/pubmed/39731134
https://www.proquest.com/docview/3201889953
https://www.proquest.com/docview/3149758563
https://pubmed.ncbi.nlm.nih.gov/PMC11681660
https://doaj.org/article/4eeaebd2551d46e18232a68cce21d46a
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9swEBf9gLGXse9l7TINBnsYXiNbseTBGElp6bqljDaBsBchy3Ib8Ow2cbL2j9r_uDvZMTUr20sepFPA96G7n6S7I-St4JpFwiYeCBwAikCb49z3ejZlUnJpIoa5w6OT8GjCj6f96QZZtzuqGbi4E9phP6nJPPtwfXXzGQz-kzN4Ge4tGF7veeBtvF4AKujJTbINnklgR4MRb24VACu4Rh89iAk8AIVynURz53-0HJWr5__3rn3LbbWfVN7yUYcPyYM6uKSDShsekQ2bPyb3RvX1-RPyex97cbhMho_0DJxWZj08uacJwuJVrYVUZ-fFfFZe_FxQXdcsoct8ZWcZDCzLwmDGIP3yDdjuEk8gaKWA2jESBRWiZUET8IqlvrYZneX0EhNLgIganJ7T1UxTTKeoDoNpkVIIQunx4CvbOxsPxpxil-Rf-uYpmRwejPePvLpfg2ewb7UXcJv6IkysYJFlxvZkGgehBZtPpbR9EWtuQxmZIIYokHMt4jiGJVr0oziBJcEzspUXuX1BaMphD4ZVqTaM6ySQcZrIMLJxpP2-MUGHsLVwlKmLmWNPjUw5UCNDVQlUgUCVE6iSHfK-WXNZlfL4J_UQZd5QYhluN1DMz1Vt1Ypbq22cACxjCQ8tYLXA16E0xvo4oDvkNWqMqnJam81EDSREWhAoCb9D3jkKVHD4AKPrrAhgAxbmalHutihhGzDt6bVWqrUVqQDCOwmIug8Me9NM40p8WpfbYgk0gJERNIZA87xS4uajA2xsxgLeIbKl3i2utGfy2YUrUs5YiFfSvZf_ZcEOue-j3bk3Qrtkq5wv7SuI9Mq4SzbFVHTJ9vDg5Ptp152XdJ1Jw-_p8McfCJRT8g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxDeFwYwE4gFFrRM3cZAQKoOpXdu9rJP6ZhznslUqSenX2B8FfyN3-WIR0t72at9Fie98d7_Yd8fY20AaEQYQOyhwBCgB7TkpXacDiVBKKhsKyh0eH_v9U3k07U532J8qF4auVVY2MTfUcWbpH3nbQ0-lEBx0vc-Lnw51jaLT1aqFRqEWQ7i8QMi2-jT4ivJ957qH3yYHfafsKuBY6q7seBISN_BjCEQIwkJHJZHnA2pmohR0g8hI8FVovQhjFSlNEEURspigG0Yxsnj43FvsNjreDoG9YFoDPMQieSMR9Mi-QziiStJRfnsl6AjSQY_odDzcJo5qOMK8X8D_XuGKW2xe2bziAw8fsPtl8Mp7hbY9ZDuQPmJ3xuXx_GP2-4B6feSZEh_5CTrFOTh0MsBjgt3bUsu5mZ_hyq7Pf6y4KWui8E26hdkcBzbrzFJGIh-MUKx5YgsGxXwJK4p0UUX5OuMoLlibXzDns5QvKHEFibil6SXfzgyndI3iZzPPEo5BLj_qDUX7ZNKbSE5dmC_M5RN2eiOSe8p20yyF54wnEm08ciXGCmliT0VJrPwQotC4XWu9FhOVcLQti6VTz465zkGT8nUhUI0C1blAtWqxDzXPoigVci31F5J5TUllvvOBbHmmS6uhJYCBKEbYJ2LpA2JBzzW-shZcGjAttk8ao4uc2dpY6Z7CSA4DscBtsfc5BZkr_ABryqwLXAYq_NWg3GtQopmxzelKK3Vp5lb636ZssTf1NHHS1b0Usg3SIAYnUOojzbNCieuP9qhxmvBki6mGejdWpTmTzs7zIuhC-HTk3Xlx_Xvts7v9yXikR4Pj4Ut2z6UNKKggwR7bXS838ApDynX0Ot_HnH2_acPxFytEiLI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correction%3A+Single-cell+deconvolution+algorithms+analysis+unveils+autocrine+IL11-mediated+resistance+to+docetaxel+in+prostate+cancer+via+activation+of+the+JAK1%2FSTAT4+pathway&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=Huang%2C+Hai&rft.au=Luo%2C+Yong&rft.au=Li%2C+Kaiwen&rft.au=Bai%2C+Shoumin&rft.date=2024-12-28&rft.pub=BioMed+Central+Ltd&rft.issn=0392-9078&rft.volume=43&rft.issue=1&rft_id=info:doi/10.1186%2Fs13046-024-03257-8&rft.externalDBID=n%2Fa&rft.externalDocID=A821585372
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-9966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-9966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-9966&client=summon